Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis. 2008

Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
Gilead Sciences, Department of Medicinal Chemistry, 333 Lakeside Drive, Foster City, CA 94404, USA. tkirschberg@gilead.com

A series of 3,4,5-trisubstituted 1,2,4-4H triazole derivatives was synthesized and investigated for HIV-1 reverse transcriptase inhibition. An X-ray structure with HIV-1 RT secured the binding mode and allowed the key interactions with the enzyme to be identified.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D020650 Combinatorial Chemistry Techniques A technology, in which sets of reactions for solution or solid-phase synthesis, is used to create molecular libraries for analysis of compounds on a large scale. Chemistry Techniques, Combinatorial,Techniques, Combinatorial Chemistry,Chemistry Technic, Combinatorial,Chemistry Technics, Combinatorial,Chemistry Technique, Combinatorial,Combinatorial Chemistry Technic,Combinatorial Chemistry Technics,Combinatorial Chemistry Technique,Technic, Combinatorial Chemistry,Technics, Combinatorial Chemistry,Technique, Combinatorial Chemistry

Related Publications

Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
December 2006, ChemMedChem,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
December 2006, ChemMedChem,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
December 2012, European journal of medicinal chemistry,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
August 2012, ACS medicinal chemistry letters,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
September 2009, Bioorganic & medicinal chemistry letters,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
June 2012, ACS medicinal chemistry letters,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
July 2010, Journal of medicinal chemistry,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
September 2003, Current medicinal chemistry,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
January 2016, Journal of enzyme inhibition and medicinal chemistry,
Thorsten A Kirschberg, and Mini Balakrishnan, and Wei Huang, and Rebecca Hluhanich, and Nilima Kutty, and Albert C Liclican, and Damian J McColl, and Neil H Squires, and Eric B Lansdon
February 2004, Journal of medicinal chemistry,
Copied contents to your clipboard!